- About us
- Access our Services
- Scientific strategy
The EU-funded ERINHA-Advance project has brought together high containment labs capable of working with the most dangerous pathogens on the planet – causing serious disease and having no treatment or vaccines available.
The project was completed in the summer of 2022 and is published on the CORDIS website.
Developing a comprehensive strategy for long-term sustainability in the fight against pandemics, it demonstrates the success of Trans National Access and the adaptability of research infrastructure in changing health contexts. No less than six user projects were accommodated by providing access to the high-containment ERINHA facilities and services. Four other projects with ‘risk group 3’ status were selected after the launch of an emergency call for proposals in response to the SARS-CoV-2 pandemic. Building on the lessons of the Covid19 pandemic and the need to strengthen our joint response capacities, ERINHA has coordinated a new EU-funded action: Integrated Service for Infectious Disease Outbreak research.
The full publication is available here
ISIDORe, an interdisciplinary project coordinated by European Research Infrastructure on Highly Pathogenic Agents (ERINHA), is funded by the European Commission Horizon-Europe programme through the HERA incubator call and brings together all key European life-sciences research infrastructures and networks, as well as those in the social sciences.
The Consortium brings together 154 partners under the umbrella of BBMRI, EATRIS, ECRIN, ELIXIR, EMBRC, EMERGEN, EUOPENSCREEN, EUROBIOIMAGING, EVA-G, INFRAFRONTIER, INFRAVEC, INSTRUCT, MIRRI, SONAR GLOBAL, TRANSVAC, VETBIONET and ERINHA.
Diana Stepanyan, Head of External Affairs
Dylan Bonfils, Communication & External Affairs Manager